Total Payments
$1,748
2024 Payments
$493.84
Companies
15
Transactions
82
Medicare Patients
4,170
Medicare Billing
$537,793
Payment Breakdown by Category
Food & Beverage$1,748 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,748 | 82 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $950.31 | 43 | $0 (2024) |
| ABBVIE INC. | $213.07 | 8 | $0 (2024) |
| Abbott Laboratories | $98.87 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $83.45 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $75.54 | 5 | $0 (2024) |
| Biocompatibles, Inc. | $70.51 | 1 | $0 (2018) |
| Lilly USA, LLC | $51.66 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $39.20 | 2 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $35.70 | 2 | $0 (2022) |
| PFIZER INC. | $28.51 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $493.84 | 19 | Novo Nordisk Inc ($318.72) |
| 2023 | $336.17 | 15 | Novo Nordisk Inc ($119.68) |
| 2022 | $369.72 | 22 | Novo Nordisk Inc ($141.21) |
| 2021 | $204.85 | 6 | Novo Nordisk Inc ($160.76) |
| 2020 | $31.45 | 2 | Novo Nordisk Inc ($19.49) |
| 2019 | $166.52 | 12 | Novo Nordisk Inc ($115.95) |
| 2018 | $145.01 | 6 | Novo Nordisk Inc ($74.50) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Biological | ||||||
| 08/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 07/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Obesity | ||||||
| 07/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes Care | ||||||
| 05/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Obesity | ||||||
| 03/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Biological | ||||||
| 03/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Respiratory | ||||||
| 02/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Biological | ||||||
| 01/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Diabetes | ||||||
| 01/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes Care | ||||||
| 12/04/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes | ||||||
| 11/30/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Diabetes | ||||||
| 09/19/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 993 | 1,489 | $331,721 | $123,411 |
| 2022 | 23 | 963 | 1,335 | $291,875 | $111,922 |
| 2021 | 19 | 1,206 | 1,790 | $436,703 | $160,296 |
| 2020 | 16 | 1,008 | 1,576 | $390,884 | $142,163 |
Total Patients
4,170
Total Services
6,190
Medicare Billing
$537,793
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 298 | $61,665 | $27,282 | 44.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 99 | 194 | $48,112 | $17,962 | 37.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 111 | 124 | $48,980 | $16,678 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 191 | $28,770 | $12,028 | 41.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 83 | 83 | $24,900 | $10,531 | 42.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 103 | 112 | $30,128 | $9,961 | 33.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 95 | 96 | $18,240 | $7,348 | 40.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 50 | 66 | $23,945 | $7,295 | 30.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 29 | 29 | $14,210 | $3,991 | 28.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 50 | $11,000 | $3,088 | 28.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 13 | $7,345 | $2,820 | 38.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 83 | 83 | $3,735 | $1,426 | 38.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 18 | 20 | $4,260 | $952.81 | 22.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,120 | $844.20 | 75.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 58 | $3,074 | $621.63 | 20.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 17 | 17 | $935.00 | $372.30 | 39.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 15 | $1,110 | $169.95 | 15.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 12 | $192.00 | $40.92 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 212 | $44,080 | $20,429 | 46.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 94 | 191 | $47,368 | $15,365 | 32.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 87 | 93 | $36,735 | $14,510 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 185 | $27,750 | $12,142 | 43.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 72 | 72 | $19,815 | $9,347 | 47.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 82 | 87 | $16,530 | $6,794 | 41.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 74 | 76 | $20,444 | $6,291 | 30.8% |
About Dr. Sandhya Chanda, MD
Dr. Sandhya Chanda, MD is a Internal Medicine healthcare provider based in Leesburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043219710.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandhya Chanda, MD has received a total of $1,748 in payments from pharmaceutical and medical device companies, with $493.84 received in 2024. These payments were reported across 82 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,748).
As a Medicare-enrolled provider, Chanda has provided services to 4,170 Medicare beneficiaries, totaling 6,190 services with total Medicare billing of $537,793. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Leesburg, VA
- Active Since 07/15/2005
- Last Updated 03/07/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1043219710
Products in Payments
- Ozempic (Drug) $528.62
- QULIPTA (Drug) $182.51
- Rybelsus (Drug) $176.28
- Wegovy (Drug) $161.60
- XARELTO (Drug) $83.45
- VARITHENA (Drug) $70.51
- FREESTYLE LIBRE 3 (Device) $56.46
- MOUNJARO (Drug) $51.66
- Veozah (Drug) $49.75
- Tresiba (Drug) $39.65
- Livalo (Drug) $35.70
- UBRELVY (Drug) $30.56
- FREESTYLE LIBRE 2 (Device) $30.46
- IMFINZI (Drug) $24.06
- Victoza (Drug) $23.73
- NURTEC ODT (Drug) $20.46
- RYBELSUS (Drug) $20.43
- AREXVY (Drug) $20.15
- Coala Heart Monitor (Device) $18.43
- AIRSUPRA (Drug) $15.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Leesburg
Dr. David Lichtinger, D.o, D.O
Internal Medicine — Payments: $17,918
Internal Medicine $17,918
Jahanbakhsh Naghshin, M.d, M.D
Internal Medicine — Payments: $13,133
Internal Medicine $13,133
Sheyla Zelaya-Aragon
Internal Medicine — Payments: $11,938
Internal Medicine $11,938
Diane Traficante, Do, DO
Internal Medicine — Payments: $9,193
Internal Medicine $9,193
Dr. Ravi Gupta, M.d, M.D
Internal Medicine — Payments: $8,000
Internal Medicine $8,000
Dr. Sepehr Mesdaghinia, M.d, M.D
Internal Medicine — Payments: $6,588
Internal Medicine $6,588